Formulary  

  •  

    DEPARTMENT OF HEALTH

    Board of Osteopathic Medicine

    RULE NO.: RULE TITLE:

    64B15-6.0038Formulary

    NOTICE OF CHANGE

    Notice is hereby given that the following changes have been made to the proposed rule in accordance with subparagraph 120.54(3)(d)1., F.S., published in Vol. 42 No. 131, July 7, 2016 issue of the Florida Administrative Register.

    The change is in response to written comments submitted by the Florida Medical Association (FMA). The Council on Physician Assistants, at its meeting held on July 28, 2016 reviewed the FMA’s written comments and voted to change the rule.  The Board reviewed the Council’s recommendation on August 26, 2016, and approved changes. The changes are as follows:

    64B15-6.0038 Formulary.

    (1) Physician Assistants approved to prescribe medicinal drugs Approve to Prescribe Medicinal Drugs under the provisions of Sections 458.347(4)(e) or 459.022 (4)(e), F.S., are not authorized to prescribe Prescribe the following medicinal drugs Medicinal Drugs, in pure form or combination:

    (a) Controlled substances, as defined in Chapter 893, F.S. Effective January 1, 2017, Physician Assistants may prescribe controlled substances, as defined in Chapter 893, F.S., with the following restrictions:

    1. Physician Assistants may not prescribe psychiatric mental health controlled substances for children younger than 18 years of age.

    2. Physician Assistants may only prescribe a 7-day supply of Schedule II controlled substances as listed in s. 893.03, F.S.

    (b)(a) General, spinal or epidural anesthetics;

    (c)(b) Radiographic contrast materials;

    (c) Psychiatric mental health controlled substances for children younger than 18 years of age.

    (2) The prescription of Schedule II controlled substances as listed in s. 893.03, Florida Statutes, is limited to a 7-day supply.

    (2)(3) A supervising physician may delegate to a prescribing physician assistant only such authorized medicinal drugs as are used in the supervising physician’s practice, not listed in subsection (1).

    (3)(4) Subject to the requirements of this subsection, Sections 456.44, 458.347, 458.3265 458.3295, and 459.022, and 459.0137, and the rules enacted thereunder, drugs not appearing on this formulary may be delegated by a supervising physician to a prescribing physician assistant to prescribe.

    (4)(5) Nothing herein prohibits a supervising physician from delegating to a physician assistant the authority to order medicinal drugs for a hospitalized patient of the supervising physician, nor does anything herein prohibit a supervising physician from delegating to a physician assistant the administration of a medicinal drug under the direction and supervision of the physician.

    Rulemaking Authority 458.347, 459.022(4) FS. Law Implemented 459.022(4)(e), 459.0137, 456.44 FS. History–New 3-12-94, Formerly 61F9-6.0038, Amended 11-30-94, 4-17-95, 8-27-95, 11-13-96, Formerly 59W-6.0038, Amended 5-12-98, 3-10-99, 3-9-00, 6-19-00, 11-23-00, 2-26-02, 2-23-04, 8-2-09,                                  .

    THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Kama Monroe, J.D., Executive Director, Board of Medicine, 4052 Bald Cypress Way, Bin #C06, Tallahassee, Florida 32399-3256.

     

Document Information

Related Rules: (1)
64B15-6.0038. Formulary